To include your compound in the COVID-19 Resource Center, submit it here.

MicOryx: Additional Phase I/IIa data

Oryx said 1 heavily pretreated patient with bulky metastases who received MicOryx in

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE